Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BVMF/BLAU3 stock hub

BVMF/BLAU3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/BLAU3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.4B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/BLAU3

In the news

Latest news · BVMF/BLAU3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E7.7

P25 n/aP50 n/aP75 n/a

Trailing P/E9.9

P25 n/aP50 n/aP75 n/a

ROE10.9

P25 n/aP50 n/aP75 n/a

ROIC10.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/BLAU3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

BRL

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Brazil
Country code	BR
Employees	1,900
Employees Change	600%
Employees Change Percent	46.15
Enterprise value	BRL 2.4B
Exchange	Brazil Stock Exchange
Financial currency	BRL
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	BRBLAUACNOR8
Last refreshed	2026-05-10
Market cap	BRL 2.4B
Price	BRL 10.44
Price currency	BRL
Rev Per Employee	928,607.89x
Sector	Healthcare
Sic	2836
Symbol	bvmf/BLAU3
Website	https://www.blau.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.11%
EV Earnings	9.89x
EV/EBIT	7.33x
EV/EBITDA	6.18x
EV/FCF	70.64x
EV/Sales	1.37x
FCF yield	1.42%
Forward P/E	7.66x
P/B ratio	1.06x
P/E ratio	9.89x
P/S ratio	1.37x
PE Ratio3 Y	9.59x
PE Ratio5 Y	13.01x
PEG ratio	0.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.65%
EBITDA Margin	21.78%
FCF margin	1.93%
Gross margin	40.44%
Gross Profit	BRL 713.5M
Gross Profit Growth	3.62%
Gross Profit Growth Q	20.58%
Gross Profit Growth3 Y	5.15%
Gross Profit Growth5 Y	2.63%
Net Income	BRL 243.8M
Net Income Growth	-9.05%
Net Income Growth Q	-56.27%
Net Income Growth Years	1%
Net Income Growth3 Y	-11.68%
Net Income Growth5 Y	-4.64%
Pretax Margin	18.47%
Profit Margin	13.82%
Profit Per Employee	BRL 128,310
Profitable Years	13
ROA	5.87
Roa5y	10.06
ROCE	11.4
ROE	10.86
Roe5y	18.51
ROIC	10.8
Roic5y	20.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	11.29%
Cagr3y	-5.22%
Cagr5y	-17.78%
Div CAGR3	8.12%
EPS Growth	-8.51
EPS Growth Q	-56.11
EPS Growth Years	0
EPS Growth3 Y	-11.72
EPS Growth5 Y	-6.93
FCF Growth	-88.66%
FCF Growth Q	279.84%
FCF Growth3 Y	-26.75%
FCF Growth5 Y	-20.48%
OCF Growth	-35.15%
OCF Growth Q	23%
OCF Growth3 Y	8.24%
OCF Growth5 Y	6.84%
Revenue Growth	-0.19x
Revenue Growth Q	16.62x
Revenue Growth Years	0x
Revenue Growth3 Y	9.29x
Revenue Growth5 Y	6.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.5
Assets	BRL 3.6B
Cash	BRL 542.2M
Current Assets	BRL 1.8B
Current Liabilities	BRL 687.8M
Debt	BRL 560.3M
Debt EBITDA	BRL 1.44
Debt Equity	BRL 0.25
Debt FCF	BRL 16.42
Equity	BRL 2.3B
Interest Coverage	2.75
Liabilities	BRL 1.3B
Long Term Assets	BRL 1.7B
Long Term Liabilities	BRL 610.8M
Net Cash	BRL -18.1M
Net Cash By Market Cap	BRL -0.75
Net Debt EBITDA	BRL 0.05
Net Debt Equity	BRL 0.01
Net Debt FCF	BRL 0.53
Tangible Book Value	BRL 1.7B
Tangible Book Value Per Share	BRL 7.19
WACC	7.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.66
Inventory Turnover	1.54
Net Working Capital	BRL 847.9M
Quick ratio	1.67
Working Capital	BRL 1.1B
Working Capital Turnover	BRL 1.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.47%
Dividend Growth	81.76%
Dividend Growth Years	1%
Dividend per share	BRL 0.36
Dividend Years	6
Dividend Yield	3.4%
Ex Div Date	2026-03-24
Last Dividend	BRL 0.08
Payout Frequency	Quarterly
Payout Ratio	25.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	11.28%
200-day SMA	10.12
3Y total return	-14.87%
50-day SMA	10.53
50-day SMA vs 200-day SMA	50over200
5Y total return	-62.41%
All Time High	42.25
All Time High Change	-75.29%
All Time High Date	2021-07-19
All Time Low	7.08
All Time Low Change	47.52%
All Time Low Date	2024-06-20
ATR	0.39
Beta	0.33
Beta1y	0.63
Beta2y	0.51
Ch YTD	-3.4
High	11.04
High52	11.84
High52 Date	2026-04-17
High52ch	-11.82%
Low	10.2
Low52	8.72
Low52 Date	2026-01-19
Low52ch	19.73%
Ma50ch	-0.85%
Price vs 200-day SMA	3.18%
RSI	47.08
RSI Monthly	45.34
RSI Weekly	50.77
Sharpe ratio	0.23x
Sortino ratio	0.48
Total Return	3.87%
Tr YTD	-2.67
Tr1m	-1.69%
Tr1w	1.95%
Tr3m	7.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 329.1M
Operating Income Growth	-17.82
Operating Income Growth Q	-22.87
Operating Income Growth3 Y	-5.76
Operating Income Growth5 Y	-5.85
Operating margin	18.65

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38,584,962%
Net Borrowing	7,460,000
Shares Insiders	83.3%
Shares Institutions	3.19%
Shares Out	230,984,962
Shares Qo Q	0%
Shares Yo Y	-0.47%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 34.1M
Average Volume	242,565x
Bv Per Share	9.93
CAPEX	BRL -255.7M
Ch1m	-1.69
Ch1w	1.95
Ch1y	4.08
Ch3m	6.21
Ch3y	-25.14
Ch5y	-68.44
Ch6m	8.84
Change	-1.79%
Change From Open	-5.09
Close	10.63
Days Gap	3.48
Depreciation Amortization	55,213,000
Dollar Volume	4,243,860
Earnings Date	2026-05-08
EBIT	BRL 329.1M
EBITDA	BRL 384.3M
EPS	BRL 1.06
F Score	6
FCF	BRL 34.1M
FCF EV Yield	1.42x
FCF Per Share	BRL 0.15
Financing CF	-131,790,000
Fiscal Year End	December
Founded	1,987
Graham Number	15.35579
Graham Upside	47.09
Income Tax	BRL 83.5M
Investing CF	-144,967,000
Is Primary Listing	1
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Date	2026-01-06
Last Split Type	Forward
Lynch Fair Value	BRL 5.28
Lynch Upside	-49.45
Ma150	10.17
Ma150ch	2.62%
Ma20	10.82
Ma20ch	-3.52%
Net CF	9,786,000
Next Earnings Date	2026-08-12
Open	11
P FCF Ratio	70.66
P OCF Ratio	8.32
Payment Date	2026-04-02
Position In Range	28.57
Ppne	1,001,632,000
Price Date	2026-05-08
Price EBITDA	BRL 6.27
Ptbv Ratio	1.45
Relative Volume	1.68x
Revenue	1,764,355,000x
Tax By Revenue	4.73x
Tax Rate	25.62%
Tr6m	15.57%
Volume	406,500

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/BLAU3 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.4%

$0.35 annual per share

Payout ratio

+25.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+3.9%

Next ex-dividend date: 2026-03-24

Performance

BVMF/BLAU3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/BLAU3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.2%

Share of float held by funds and institutions

Insider ownership

+83.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.5%

Negative means the company is buying back shares.

Technical

BVMF/BLAU3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.1

Neutral momentum band

Price vs 200-day MA

+3.2%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/BLAU3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/BLAU3 stock rating?

bvmf/BLAU3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/BLAU3 analysis?

The full report lives at /stocks/bvmf/BLAU3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/BLAU3?

The latest report frames bvmf/BLAU3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/BLAU3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.